Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-037645
Filing Date
2018-06-14
Accepted
2018-06-14 11:52:39
Documents
1
Period of Report
2018-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4205
  Complete submission text file 0001209191-18-037645.txt   5522
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08450
Business Address
Berrey M Michelle (Reporting) CIK: 0001397329 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 18898604